glp 1 hormone production Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1-based therapies for type 2

Abstract The anorexigenic peptide glucagon-like peptide-1 (GLP-1) is secreted from gut enteroendocrine cells and brain preproglucagon (PPG) neurons, which respectively define the peripheral and central GLP-1 systems

The researchers compared the one-year risk of heart failure hospitalization or death in new users of each GLP-1 drug to the risk of those outcomes in a placebo group of patients taking sitagliptin, a diabetes drug known to have no impact on HFpEF

As clinicians continue to address the growing overlap between obesity, diabetes, and chronic pain, GLP-1 therapies are attracting attention as a potentially broader metabolic intervention

But they may also be viewed or treated differently by their partners and others, especially if theres substantial weight loss

99% HPLC, lyophilized

IV, intravenous